Cite
HARVARD Citation
Sibley, C. et al. (2015). A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Annals of the rheumatic diseases. 74 (9), pp. 1714-1719. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sibley, C. et al. (2015). A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Annals of the rheumatic diseases. 74 (9), pp. 1714-1719. [Online].